Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gliatech To Submit Third-Party Audit Data To FDA In The Third Quarter

This article was originally published in The Gray Sheet

Executive Summary

Gliatech remains on schedule to submit an independent clinical study site audit report in the third quarter related to its Adcon-L gel anti-adhesion product for lumbar surgery, the firm says.
Advertisement

Related Content

Gliatech Weighing Adcon Sale, Bankruptcy Filing; DoJ Makes Example Of Firm
Gliatech Weighing Adcon Sale, Bankruptcy Filing; DoJ Makes Example Of Firm
Adcon Data Will Be Evaluated By Third Party In Wake Of FDA Action - Gliatech
Adcon Data Will Be Evaluated By Third Party In Wake Of FDA Action - Gliatech
Advertisement
UsernamePublicRestriction

Register

MT014896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel